Research Article
A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma
Table 1
Characteristics of clear cell renal cell carcinoma patients.
| | Characteristics | Entire cohort (513), N (%) | Training cohort (257), N (%) | Validation cohort (256), N (%) | p-Value |
| | Age (years) | | | | | | ≤60 | 262 (51.1) | 134 (52.1) | 128 (50) | 0.628 | | >60 | 251 (48.9) | 123 (47.9) | 128 (50) | | | Gender | | | | | | Female | 176 (34.3) | 89 (34.6) | 87 (34.0) | 0.878 | | Male | 337 (65.7) | 168 (65.4) | 169 (66.0) | | | Stage | | | | | | I | 255 (49.7) | 121 (47.1) | 134 (52.3) | 0.700 | | II | 56 (10.9) | 28 (10.9) | 28 (10.9) | | | III | 117 (22.8) | 62 (24.1) | 55 (21.5) | | | IV | 82 (16.0) | 45 (17.5) | 37 (14.5) | | | Unknown | 3 (0.6) | 1 (0.4) | 2 (0.8) | | | Stage T | | | | | | T1 | 261 (50.9) | 125 (48.6) | 136 (53.1) | 0.401 | | T2 | 68 (13.3) | 35 (13.6) | 33 (12.9) | | | T3 | 173 (33.7) | 89 (34.6) | 84 (32.8) | | | T4 | 11 (2.1) | 8 (3.1) | 3 (1.2) | | | Stage N | | | | | | N0 | 229 (44.6) | 114 (44.4) | 115 (44.9) | 0.566 | | N1 | 16 (3.1) | 6 (2.3) | 10 (3.9) | | | Unknown | 268 (52.2) | 137 (53.3) | 131 (51.2) | | | Stage M | | | | 0.430 | | M0 | 407 (79.3) | 198 (77.0) | 209 (81.6) | | | M1 | 78 (15.2) | 43 (16.7) | 35 (13.7) | | | Unknown | 28 (5.5) | 16 (6.2) | 12 (4.7) | | | Grade | | | | 0.290 | | G1 | 12 (2.3) | 4 (1.6) | 8 (3.1) | | | G2 | 219 (42.7) | 108 (42.0) | 111 (43.4) | | | G3 | 201 (39.2) | 106 (41.2) | 95 (37.1) | | | G4 | 78 (15.2) | 39 (15.2) | 39 (15.2) | | | Unknown | 3 (0.6) | 0 (0.0) | 3 (1.2) | | | Aeoadjuvant treatment | | | | 0.464 | | Yes | 17 (3.3) | 10 (3.9) | 7 (2.7) | | | No | 496 (96.7) | 247 (96.1) | 249 (97.3) | | | Alive status | | | | 0.901 | | Alive | 344 (67.1) | 173 (67.3) | 171 (66.8) | | | Died | 169 (32.9) | 84 (32.7) | 85 (33.2) | |
|
|
